RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.
about
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progressionTargeting DNA damage response in cancer therapyHigh MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaCold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the coldRNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection.Proteome-wide epitope mapping of antibodies using ultra-dense peptide arraysHigh expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.Widespread regulation of miRNA biogenesis at the Dicer step by the cold-inducible RNA-binding protein, RBM3Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryDecreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.Discovery of dachshund 2 protein as a novel biomarker of poor prognosis in epithelial ovarian cancer.The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study.Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer.Spatiotemporal pattern of RNA-binding motif protein 3 expression after spinal cord injury in rats.Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model.Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification.Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration.High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast CancerUpregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma PatientsReduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
P2860
Q21203667-E61A54D7-97C5-4413-B5AC-F5C7B2DE7DDAQ27023204-62EFFB18-02C1-40F1-B0EE-F3C5ED65783FQ27498879-C587EB9C-C116-4221-AE19-DC1BF7964CD0Q28079941-F2A0ACAC-2718-4636-A0F6-9134C7A12CE2Q33591883-1A64A45B-469A-49FA-9D78-87F9A158E2AEQ33718734-F8E110AB-DDEB-4AC7-90AF-94F2C18B1BF6Q33794854-2B2837E5-EEF8-4D9C-B79E-9C83FD3D415BQ34028486-1493DC25-3841-479E-8758-D55817E2A52CQ34092497-91345364-5191-4F7D-94E8-42289835BA27Q34239193-B56CA612-9911-4DC6-8B0D-87BF7FCA6879Q34658794-D2931536-59D9-4C1A-8623-48B667742FF7Q35219992-B16A44F5-A146-421A-AA78-42B3DBD37778Q35808778-CA775A08-5A7B-4F43-BCFB-BB4465F06502Q35946017-F1D18213-25D3-4892-97AD-6BF4F088C419Q36544617-3195A32F-363A-45FD-A884-40F4911588FFQ36769318-D985DCDC-5639-4605-929B-3490E9D88BCCQ37042308-67A44B22-CE3B-4967-8679-A2E5F3F49E27Q37610455-FA55F4C7-68DB-4612-A126-34A730258FECQ37697790-94214F29-71D0-4E50-B1CD-362FB68A24B7Q39370408-6F0CED7B-5318-4507-8717-77EC464FEC2FQ41117948-B6B903DF-F2B4-4A11-BBD4-B5057AFF3D59Q42424860-0F2A8F3E-5FF0-400A-98F5-A1E4108D9E36Q43658960-DBF70039-E81D-4F83-9A13-A1D9FB19D460Q45199929-DA8F5A7F-9EFC-43E3-937E-852476C6E065Q47200415-8BBD99D8-00C3-456E-A270-1C040168C778Q47268922-CAEEDADF-36BD-4267-B952-6C1986F008D8Q49787574-8B0B8E52-C415-4E78-97CE-B75896B9326EQ54979442-CF2852AE-DC8D-4EEF-88CD-504B40D17C7EQ57124774-89AE608A-D753-497C-8F42-9FC8C80986BAQ58603880-FF659803-A6D4-4F8A-9526-21D6B058091BQ59136204-41CEE556-0D86-4087-9F0C-2E46456CEEF3
P2860
RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@ast
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@en
type
label
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@ast
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@en
prefLabel
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@ast
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@en
P2093
P2860
P50
P356
P1476
RBM3-regulated genes promote D ...... in epithelial ovarian cancer.
@en
P2093
Donal J Brennan
Elton Rexhepaj
Jenny Brändstedt
P2860
P304
P356
10.1593/TLO.11106
P577
2011-08-01T00:00:00Z